Authors and Disclosures

MEC requires that those involved in the content development or presentation of this CME activity disclose to participants any significant financial interest or other relationship with (1) the manufacturer of any commercial product or provider of commercial services and (2) any commercial supporter of the activity. This CME activity may include discussions regarding the use of medications that may be outside the approved labeling for these products. Physicians should consult the current prescribing information for these products. Medical Education Collaborative requires the speaker to disclose that the product is not labeled for the use under discussion. Compliance is documentation that demonstrates the provider has a practice in place to make this requirement known to the faculty.

Authors

Bruce Cree, MD, PhD, MCR

Assistant Professor of Neurology
Multiple Sclerosis Center at UCSF
San Francisco, California

Sources of Funding for Research: Genentech, Inc Consulting Agreements: Genentech, Inc Speakers' Bureau/Honorarium Agreements: Biogen Idec; EMD Serono, Inc; Teva Neuroscience, Inc Financial Interests/Stock Ownership: None Discussion of Off-Label, Investigational, or Experimental Drug Use: Cladribine; fingolimod; fumarate; laquinimod; teriflunomide

Bruce A. Cohen, MD

Professor, Davee Department of Neurology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Sources of Funding for Research: Biogen Idec; EMD Serono, Inc; Novartis Pharmaceuticals Corp Consulting Agreements: Bayer HealthCare Pharmaceuticals Inc; Biogen Idec; Novartis Pharmaceuticals Corp; Pfizer Inc; EMD Serono, Inc; Teva Neuroscience, Inc Speakers' Bureau/Honorarium Agreements: Bayer HealthCare Pharmaceuticals Inc; EMD Serono, Inc; Pfizer Inc; Teva Neuroscience, Inc Financial Interests/Stock Ownership: Abbott Laboratories; CVS/Caremark Discussion of Off-Label, Investigational, or Experimental Drug Use: None

Patricia K. Coyle, MD

Acting Chair, Department of Neurology
Stony Brook University Medical Center;
Director, Stony Brook Multiple Sclerosis
Comprehensive Care Center
Stony Brook, New York

Sources of Funding for Research: Bayer HealthCare Pharmaceuticals Inc.; EMD Serono, Inc; Teva Neuroscience, Inc Consulting Agreements: Bayer HealthCare Pharmaceuticals Inc.; EMD Serono, Inc; Teva Neuroscience, Inc Speakers' Bureau/Honorarium Agreements: Bayer HealthCare Pharmaceuticals Inc.; EMD Serono, Inc; Teva Neuroscience, Inc Financial Interests/Stock Ownership: None Discussion of Off-Label, Investigational, or Experimental Drug Use: None

Clyde E. Markowitz, MD

Director, MS Center
Assistant Professor of Neurology
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Sources of Funding for Research: Bayer HealthCare Pharmaceuticals Inc; Biogen Idec; BioMS Medical Corp; EMD Serono, Inc; Genentech, Inc; Opexa Therapeutics; PDL BioPharma, Inc; Pfizer Inc; Teva Neuroscience, Inc Consulting Agreements: HealthCare Pharmaceuticals Inc; Biogen Idec; BioMS Medical Corp; EMD Serono, Inc; Genentech, Inc; Teva Neuroscience, Inc Speakers' Bureau/Honorarium Agreements: Bayer HealthCare Pharmaceuticals Inc, Biogen Idec; EMD Serono, Inc; Genentech, Inc; Pfizer Inc; Teva Neuroscience, Inc Financial Interests/Stock Ownership: None Discussion of Off-Label, Investigational, or Experimental Drug Use: None

The employees of Medical Education Collaborative have no financial relationships to disclose.

Copyright © 2007 Medical Education Collaborative, Inc.